Product
Supplier
Encyclopedia
Inquiry
Home > Dulaglutide for Sale > Dulaglutide CAS NO. 923950-08-7
Dulaglutide CAS NO. 923950-08-7 buy - large image1
Dulaglutide CAS NO. 923950-08-7 buy - image1

Dulaglutide CAS NO. 923950-08-7

2 Inquiries

Unit Price: Get Latest Price
CAS No.:

923950-08-7

Grade:

Research grade

Port:

SHANGHAI

Packaging:

0.001kg/Bottle

Price valid (until):

2020-12-31

Company Type:
Manufactory
Location:
China
Payment Terms:
TT against copy of documents
Average Lead Time:
7 days
Qualification:
Main Products:

Pharmaceutical Peptide,Cosmetic peptide,Custom peptides,API polypeptide,Amino acids and derivatives,Peptide - Teriparatide

  • Product Description

  • Seller Information

  • Inquiry History

  • Description

    Product Name:Dulaglutide

    Synonyms:Dulaglutide - solution in PBS

    CAS No.:923950-08-7

    Catalog No.:GT-F002

    Key Specification:

    Appearance:  White powder
    Purity (HPLC) ≥95.0%
    Acetate Content(HPLC): 10.0%
    Water Content (Karl Fischer) ≤8.0%

    Package:

     Vacuum-packed with aluminum foil bag or transparent bag. 500mg,1g, 10g,50g 100g per package with icebag. Or according to your request.

    Product Detail

    Dulaglutide is a new long-acting GLP-1R agonist. It is obtained by fusion of two GLP-1 analogues with DPP-4 inhibitory effect and human immunoglobulin heavy chain IgG4-Fc fragment. Its activity is comparable to that in clinical manifestations. Endogenous GLP-1 is similar, with a half-life of 5 days, which can effectively delay the clearance of the kidneys. The FDA approved the marketing of dulaglutide subcutaneous injection in September 2014. The European Commission approved dulaglutide subcutaneous injection in Europe in December 2014.

    Storage:Cool dry place( Store at -20°C, away from the light)

    Remark:For Research Use Only. Not for human use.

    ECHEMI Editorial Reference

    Dulaglutide is a long-acting GLP-1 receptor agonist and peptide-based pharmaceutical ingredient. As a pharmaceutical raw material, Dulaglutide is widely used in API research, pharmaceutical development, analytical testing, and manufacturing processes. It is available in high-purity grades with specifications based on pharmaceutical quality requirements.

    Basic Info
    Product Name:

    Dulaglutide

    Other Name:

    Dulaglutide - solution in PBS;Dulaglutide USP/EP/BP;Dulaglutide;Research Grade Dulaglutide(DHE40129);Research Grade Dulaglutide;Dulaglutide (Trulicity;LY2189265);Dulaglutide(sodium salt)

    CAS No.:

    923950-08-7

    Molecular Weight:

    0

    EC Number:

    200-001-8

    Color/Form:

    Colorless to light yellow

    Research
    Class:

    GLP-1 receptor agonist (GLP-1 analog fused to human IgG4-Fc, long-acting)

    Status:

    FDA-approved (Trulicity 2014)

    Mechanism:

    A long-acting GLP-1 receptor agonist consisting of a modified human GLP-1 molecule (7-37) covalently linked to a modified human IgG4 Fc fragment via a small peptide linker. The Fc fusion extends the half-life to ~5 days. Activates GLP-1R to enhance glucose-dependent insulin secretion, suppress glucagon, and slow gastric emptying.

    Activity note:

    Dulaglutide is a dual-agonist with GLP-1R activation. The exact EC50 is proprietary; functional potency is comparable to other long-acting GLP-1R agonists.

    Source:

    DrugBank: DB09095; PubChem CID 16135271.

    Clinical Development:

    NCT01394952; NCT01391252

    FDA:

    Trulicity (approved 2014-09-18)

    References
    DrugBank:

    DB09095

    PubChem:

    PubChem

    Disclaimer:

    Dulaglutide is FDA-approved as a prescription medicine (Trulicity) for type 2 diabetes. This listing is for industrial and laboratory research use only. Research-chemical listings on B2B marketplaces are not interchangeable with approved medicines. Confirm CAS, specification, and regulatory pathway with the seller. It is not medical advice, a clinical recommendation, or an approved therapy description.

  • Seller Information
    Business Type:

    Manufactory

    Main Products:

    Pharmaceutical Peptide,Cosmetic peptide,Custom peptides,API polypeptide,Amino acids and derivatives,Peptide - Teriparatide

    Location:

    5th Floor, Building 1, No. 600 Yinhai Street, Xiasha Street

    Payment Terms:

    TT against copy of documents

    Average lead Time:

    7 days

    Total Annual Revenue:

    $10 million-$25 million

    Total Employees:

    51-100

    Year of Establishment:

    2014

    Hangzhou Go Top Peptide Biotech , established in 2014, is a technology-based peptide company and a National High-tech Enterprise located in Hangzhou of China. It is also the governing unit of Peptide Branch of China Biochemical Pharmaceutical Industry Association. 

    The company currently has a peptide research center in Hangzhou, covering an area of 2,000m2 . There are two cooperation plants for peptide commercialization located in Shangyu and Anji of Zhejiang province.  The peptide center has equipped with several complete peptide productions lines, including several large-scale peptide synthesizers and advanced imported HPLC systems with different sizes. We also have GMP standard clean laboratories to meet client’s special needs. The company has passed ISO9001:2015 certification.

    At present, the company has developed more than 40 mature pharmaceutical peptides, with the annual production capacity up to 100 kilograms. With a total of 20,000 custom peptides so far, we can provide the one-stop peptide services from research scale (mg) - pilot scale - commercial production(KGs).


    English web site  https://www.gtpeptide.com

    Products and Services

    1.Custom peptide synthesis, such as Research peptide, Neoantigen peptide, Clinical peptide.

    2.Pharmaceutical peptide development and production.

    3.Peptide CRO and CDMO.

    4. Cosmetic peptide and formulation development.

    5. Special protected amino acids and small molecules.

    6. Commercialized peptide library.

    7. Technical support of new drug development.


    SHELLY HUDirector of sales13735575465sales1@gotopbio.com
       Cindy MeiThe sales manager13588827304sales3@gotopbio.com




  • Inquiry History
    2 Inquiries
    Country Product Purchase Quantity Date Posted
    Turkey

    Dulaglutide

    1 G Jun 5, 2026
    United States

    dulaglutide

    4  Mar 11, 2026
    Post an enquiry for this product

More from this Seller

pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.